Depressive Disorder: all 4,846 studies
Page 27 of 49. Open to participants first (508), then studies with results posted, then the rest; newest registration first within each.
- Peer-led Group Intervention for Coping With DisasterCompletedNCT03907995Not applicable
- Whole-body Hyperthermia for Mild to Moderate Depressive DisorderCompletedNCT03906175Not applicable
- Whole-body Hyperthermia for Moderate to Severe Depressive DisorderCompletedNCT03906149Not applicable
- Transcranial Alternating Current Stimulation Treating Post-stroke DepressionStatus unknownNCT03903068Not applicable
- Citalopram Titration in Early Non-responder Patients With Major Depressive DisordersCompletedNCT03899285Phase 2
- Study on the Effect of PRKCB1 Modulating Inflammatory Factors and the Role for Developing Major Depressive DisorderStatus unknownNCT03899194Not applicable
- Confirmation Bias Towards Treatments of Depressive Disorders in Social TaggingCompletedNCT03899168Not applicable
- Floatation-REST (Reduced Environmental Stimulation Therapy) for Anxiety and DepressionActive, not recruitingNCT03899090Not applicable
- Title: Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST)WithdrawnNCT03895658Phase 1
- Gut Feeling: Understanding the Mechanisms Underlying the Antidepressant Properties of ProbioticsCompletedNCT03893162Not applicable
- Investigate the Clinical Responses of Ethosuximide in Patients With Treatment-Resistant Depression.CompletedNCT03887624Early Phase 1
- DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using AripiprazoleStatus unknownNCT03881449Phase 4
- The Effect of Probiotic Supplementation on the Mental Status, Inflammation, and Intestinal Barrier in Major Depressive Disorder Patients Using Gluten-free or Gluten-containing DietStatus unknownNCT03877393Not applicable
- Scopolamine in Healthy VolunteersStatus unknownNCT03874130Phase 1
- Major Depressive Disorder: Early Prediction of Non-response to Antidepressant Therapy Via a Mobile Digital ScaleTerminatedNCT03872492Not applicable
- N-3 Fatty Acids as the First-line Antidepressant Therapy: From Biomarkers to Clinical SubtypesCompletedNCT03871088Not applicable
- Nitrous Oxide for the Treatment of Major Depressive DisorderCompletedNCT03869736Phase 2
- LSD Therapy for Persons Suffering From Major DepressionCompletedNCT03866252Phase 2
- iPad Application-based Intervention for Post-stroke DepressionStatus unknownNCT03864484Not applicable
- Poststroke Depression of Clinical Trial RegistrationStatus unknownNCT03863951
- Effects of Acute Prucalopride Administration in Healthy VolunteersCompletedNCT03863366Not applicable
- Screening for Depression in cADiovasCular pAtients at a Tertiary Center in Trinidad.CompletedNCT03863262
- Study of Rapastinel as Monotherapy in Major Depressive Disorder (MDD)WithdrawnNCT03855865Phase 3
- Stress, Anxiety, and Mood Group TherapySuspendedNCT03855683Not applicable
- A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant DepressionWithdrawnNCT03852160Phase 3
- Machine Learning to Predict Clinical Response to TMSStatus unknownNCT03847688
- The Recovery of Cardiovascular Patients With DepressionStatus unknownNCT03841474Not applicable
- Efficacy of Brief Acceptance and Commitment Therapy (ACT) for Perinatal AnxietyCompletedNCT03837392Not applicable
- Study With Vortioxetine on Emotional Functioning in Patients With DepressionCompletedNCT03835715Phase 4
- Glabellar Botulinum Toxin Injections for the Treatment of Geriatric DepressionWithdrawnNCT03833063Phase 1
- Patient Outcomes Reporting for Timely Assessments of Life With Depression: PORTAL-DepressionCompletedNCT03832283Not applicable
- Pre-Approval Access to Esketamine Nasal Spray for the Treatment of Treatment-Resistant Depression (TRD)Approved for marketingNCT03829579
- Self-acupressure for Cancer-related Symptom Cluster of Insomnia, Depression, and Anxiety: a Feasibility StudyStatus unknownNCT03823456Not applicable
- A Relative Bioavailability Food Effect Study of LY03005CompletedNCT03822065Phase 1
- Volunteering as an Intervention to Reduce Depression Among AdolescentsCompletedNCT03816215Not applicable
- Lithium Therapeutic Drug Monitoring; Once Daily Vs Twice Daily Dosing and the Impact of Kidney FunctionStatus unknownNCT03811860Not applicable
- Zero-time Exercise for DepressionCompletedNCT03811327Not applicable
- Adolescent Depression Associated With Parental DepressionTerminatedNCT03811041Not applicable
- Apathy in Late Life Depression: New Biomarkers Using Actimetry and Magnetic Resonance ImagingCompletedNCT03807167Not applicable
- Accelerated Intermittent Theta-Burst Stimulation for Opiate Use DisorderWithdrawnNCT03804619Not applicable
- Predicting the Development of Myocardial Depression in Acute Neurological PatientsCompletedNCT03801694
- The Role of Sex Steroids and Serotonin Brain Dynamics in Perinatal Mental HealthCompletedNCT03795688
- Coil Positioning in Navigated Transcranial Magnetic Stimulation Feasibility in Depression Patients TrialCompletedNCT03795051Not applicable
- Does Enhancing Maternal Peer Interactions Decrease Rates of Postpartum Depression?CompletedNCT03793569Not applicable
- Early Diagnosis of PPD Through Self-portraitsCompletedNCT03791021
- Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia IndividualsStatus unknownNCT03790085Early Phase 1
- Affective Touching on Poststroke DepressionStatus unknownNCT03789994Not applicable
- A Transdiagnostic Sleep and Circadian Treatment for Major Depressive DisorderStatus unknownNCT03786731Not applicable
- Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LY03005 Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)CompletedNCT03785652Phase 1
- EXperimental Paradigm to Investigate Expectation Change in Depression 4CompletedNCT03780881Not applicable
- Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic AssessmentCompletedNCT03779789Phase 4
- Effect of Coping With Stress Program to Depression, Anxiety, Brain Functions in Adolescent at High-Risk for DepressionCompletedNCT03779477Not applicable
- A Transdiagnostic Sleep and Circadian Treatment for DepressionCompletedNCT03775148Not applicable
- A Pilot Study of Prophylactic Management of Lamotrigine in Pregnant WomenCompletedNCT03774641
- Waitlist-Control Trial of Smartphone CBT for Major Depressive Disorder (MDD), WithdrawnWithdrawnNCT03769350Not applicable
- Impact of Exercise on "Invisible" Symptoms and Quality of Life in Multiple Sclerosis IndividualsCompletedNCT03768830Not applicable
- Vortioxetine Intravenous Infusion at Initiation of Oral Treatment With Vortioxetine in Patients With DepressionCompletedNCT03766867Phase 2
- Vitamin D Supplementation in Patients With DepressionStatus unknownNCT03766074Not applicable
- The Effects of Pregnancy Classes and Contributing Factors to Postpartum DepressionStatus unknownNCT03763435
- rTMS as an add-on Therapy in Patients With Post-stroke DepressionWithdrawnNCT03761303Not applicable
- Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and Functional Magnetic Resonance Imaging (fMRI) Studies of Schizophrenia and DepressionWithdrawnNCT03758495
- Influenza Vaccine as a Novel Experimental Model of the Behavioral Immune Response in DepressionStatus unknownNCT03756246Phase 4
- Effect of Vitamin D Administration Along With SSRIs in Patients With Major Depressive DisorderStatus unknownNCT03754712Not applicable
- Comparative Effectiveness of Pharmacogenomics for Treatment of DepressionCompletedNCT03749629Not applicable
- Sleep Subtypes in Adolescent DepressionCompletedNCT03742960Not applicable
- Evaluation of Schemes of Administration of Intravenous Ketamine in DepressionStatus unknownNCT03742557Phase 3
- The Impact of Anxiety or Depression on the Sedative Concentration of PropofolCompletedNCT03741361
- The Police-Mental Health Linkage SystemCompletedNCT03740139Not applicable
- Study to Explore the Effective Doses and to Assess the Safety and Efficacy of Hypidone Hydrochloride TabletsCompletedNCT03739632Phase 2
- Cognitive Behavioural Therapy for the Treatment of Late Life DepressionCompletedNCT03735576Not applicable
- A Study of LY03005 vs PristiqCompletedNCT03733574Phase 1
- Role of Omega-3 Polyunsaturated Fatty Acid in the Management of Major Depressive Disorder.CompletedNCT03732378Not applicable
- Group CBT and Exercise in Management of DepressionTerminatedNCT03731728Not applicable
- Brain Imaging to Understand the Role of Inflammation in N-Acetyl Cysteine (NAC) Treatment of Bipolar DepressionCompletedNCT03730064Early Phase 1
- Research on the Effects of Combined Neurostimulation Protocols on StressCompletedNCT03722095Not applicable
- Ketamine for Major Depressive DisorderStatus unknownNCT03721900Phase 1
- Clinical and Suicidal Features of Urban, Turkish Middle Age Depressive Patients With Comorbid ADHDCompletedNCT03721588
- Lifestyle Medicine for DepressionStatus unknownNCT03720145Not applicable
- Efficacy and Safety of Accelerated Transcranial Magnetic Stimulation With H1-coil (dTMS)CompletedNCT03718013Not applicable
- Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of ConceptCompletedNCT03715127Phase 2
- Effects of Transcendental Meditation on Physician Burnout and DepressionCompletedNCT03714204Not applicable
- An Eye Tracking Study of Affective Disorder Patients With Suicide RiskStatus unknownNCT03711045
- Efficacy of Convulsive Therapies During ContinuationCompletedNCT03711019Not applicable
- Pacifiers and Breastfeeding Among Mothers at Risk for Postpartum DepressionWithdrawnNCT03709004Not applicable
- rTMS and Cognitive Training in Youth DepressionCompletedNCT03708172Not applicable
- Maintenance of Response After rTMS for Depression Using tDCSCompletedNCT03708159Not applicable
- Efficacy of Psychotherapy for Improving Quality of Life in Patients With Hypertrophic Cardiomyopathy and DepressionStatus unknownNCT03706001Not applicable
- Characterization of Microbial, Immune and Epigenetic Biomarkers for Major Depressive Disorder and ECT TreatmentStatus unknownNCT03703414
- Cost-utility Analysis of Maintenance rTMS for Treatment-resistant DepressionStatus unknownNCT03701724Not applicable
- The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal CognitionTerminatedNCT03693105Phase 2/3
- Dignity Therapy for Patients With Early Dementia and Their FamilyCompletedNCT03692988Not applicable
- Treatment of Depression With Mindfulness, Acceptance and CommitmentStatus unknownNCT03692130Not applicable
- Evaluation of Metacognitive Training for Depression in Later Life (MCT-Silver)CompletedNCT03691402Not applicable
- Efficacy of Light Therapy Device LUMINETTE® in Major Depressive DisorderCompletedNCT03685942Not applicable
- Online Cognitive Behaviour Therapy for Depression and Anxiety: Randomized Controlled Trial Varying Treatment ContentCompletedNCT03684434Not applicable
- Triple Chronotherapy in AdolescentsCompletedNCT03679962Not applicable
- Motoric Cognitive Risk and DepressionActive, not recruitingNCT03679221
- Music to Improve Sleep Quality in Adults With Depression and InsomniaCompletedNCT03676491Not applicable
- Ketamine Versus Electroconvulsive Therapy in DepressionSuspendedNCT03674671Phase 3
- Impairment of the Cognitive Flow in the Development of a Depressive Disorder and Suicidal IdeasCompletedNCT03674580